Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Karl Illig

Vascular Surgery Tampa, FL Medical Doctor

NPI 1023053303 CMS profile 182156

2 Tampa General Cir, Usf Vascular Surgery Ste.300, Tampa, FL 33606

Open in the dashboard

General payments

$38,494

98 records reported · program years 2019–2025

Research payments

$48,455

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$37,104 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Karl Illig of Tampa, FL is reported in the CMS Open Payments database as having received $38,494 across 98 general payments and $48,455 in research payments paid to them. Separately, studies naming them as principal investigator received $37,104 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,504 16
2024 General $2,050 2
2024 Research $47,100 1
2023 General $558 5
2022 General $9,467 10
2021 General $1,401 15
2020 General $2,477 7
2020 Research $1,355 1
2019 General $3,037 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Karl Illig
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Karl Illig were reported at $19,504. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Karl Illig Vascular Surgery median Middle half National median
2019 $3,037 $796 $226–$2,363 $163
2020 $2,477 $348 $118–$1,110 $114
2021 $1,401 $471 $158–$1,421 $132
2022 $9,467 $725 $222–$2,183 $149
2023 $558 $836 $257–$2,440 $160
2024 $2,050 $909 $252–$2,619 $164
2025 $19,504 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merit Medical Systems Inc $30,595 21 payments
  2. W. L. Gore & Associates, Inc. $2,632 30 payments
  3. Artegraft Inc. $2,445 3 payments
  4. Medtronic, Inc. $626 7 payments
  5. LeMaitre Vascular, Inc. $475 10 payments
  6. Medistim USA, Inc. $423 2 payments
  7. Boston Scientific Corporation $324 8 payments
  8. Bard Peripheral Vascular, Inc. $308 8 payments
  9. Medtronic Vascular, Inc. $277 2 payments
  10. Maquet Cardiovascular U.S. Sales, L.L.C. $146 2 payments
  11. Other $244 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $13,920 7 payments
  2. Consulting Fee $11,725 5 payments
  3. Travel and Lodging $6,995 9 payments
  4. Food and Beverage $5,854 77 payments
Products named General payments · program years 2019–2025
  1. HeRO Graft $7,923 5 payments
  2. Surfacer Inside-Out Catheter $7,886 4 payments
  3. VIABAHN Endoprosthesis $1,134 17 payments
  4. VIABAHN VBX Balloon Expandable Endoprosthesis $512 4 payments
  5. GORE VIABAHN Endoprosthesis with Heparin $510 6 payments
  6. MiraQ $423 2 payments
  7. ENDURANT IIS $376 3 payments
  8. ANASTOCLIP $370 8 payments
  9. GORE VIABAHN VBX Balloon Expandable Endo $245 1 payment
  10. Chameleon $170 3 payments
  11. Other $1,708 29 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medistim USA, Inc. $47,100 1 payment
  2. Cook Research Incorporated $1,355 1 payment

Records

100 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record